Sr. Research Advisor, Group Leader, Cancer Biology and Patient Tailoring @ Eli Lilly and Company
Sr. Research Advisor @ Eli Lilly and Company
Senior Principal Scientist @ Eli Lilly and Company
Jeremy Graff's Education
The Johns Hopkins University School of Medicine
Post-Doctoral Fellow (Epigenetic Silencing of Tumor and Metastasis Suppressor Genes)
1995 - 1998
University of Kentucky
PhD (Mechanisms of ras-induced metastatic progression)
1989 - 1994
Thomas More College
BA and AA (Biology and Chemistry)
1985 - 1989
Covington Latin School
Diploma (Accelerated College Prepatory Curriculum)
1981 - 1985
University of Kentucky
Doctor of Philosophy - PhD (Cancer Metastasis)
Jeremy Graff's Skills
Assay Development
Molecular Biology
Biochemistry
Cancer
Drug Development
Sales
Clinical Trials
Research
Program Management
Biotechnology
Jeremy Graff's Summary
Jeremy Graff, based in Saint Paul, MN, US, is currently a Chief Scientific Officer, IMV, Inc. at IMV Inc., bringing experience from previous roles at HiberCell, Biothera Pharmaceuticals, Inc., Biothera and Eli Lilly and Company. Jeremy Graff holds a 1995 - 1998 Post-Doctoral Fellow in Epigenetic Silencing of Tumor and Metastasis Suppressor Genes @ The Johns Hopkins University School of Medicine. With a robust skill set that includes Assay Development, Molecular Biology, Biochemistry, Cancer, Drug Development and more, Jeremy Graff contributes valuable insights to the industry. Jeremy Graff has 6 emails on RocketReach.